Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (5) | B (2) | C (4) | D (4) | E (8) | F (1) | G (4) | I (3) | L (3) | N (1) | O (2) | P (2) | R (1) | S (6) | T (7) | U (1) | V (1) | W (2)
Generic Name Common Trade Name(s) Classificationsort icon Date Marketed in Canada (yyyy/mm/dd)
White birch extract (Betula verrucosa) Itulatek Allergy immunotherapy 2020/09/28
Apalutamide Erleada Anti-androgen 2018/07/27
Darolutamide Nubeqa Anti-androgen 2020/03/24
Fremanezumab Ajovy Anti-calcitonin gene-related peptide 2020/08/04
Warfarin Coumadin Anticoagulant 2020/04/23
Esketamine Spravato Antidepressant 2020/05/20
Ribociclib Kisqali Antineoplastic agent 2018/11/26
Cemiplimab Libtayo Antineoplastic agent 2019/05/24
Alpelisib Piqray Antineoplastic agent 2020/03/11
Axicabtagene ciloleucel Yescarta Antineoplastic agent 2019/11/27
Trastuzumab deruxtecan Enhertu Antineoplastic agent 2021/04/15
Entrectinib Rozlytrek Antineoplastic agent
Gilteritinib Xospata Antineoplastic agent 2020/02/03
Glasdegib Daurismo Antineoplastic agent 2020/08/10
Larotrectinib Vitrakvi Antineoplastic agent 2019/07/10
Niraparib Zejula Antineoplastic agent 2020/01/09
Sonidegib Odomzo Antineoplastic agent 2020/06/11
Tucatinib Tukysa Antineoplastic agent 2020/10/08
Daratumumab Darzalex SC Antineoplastic agent, monoclonal antibody 2020/08/12
Isatuximab Sarclisa Antineoplastic agent, monoclonal antibody 2020/07/03
Brolucizumab Beovu Antineovascularisation agent 2020/05/15
Cabotegravir Vocabria Antiretroviral agent 2020/03/19
Cabotegravir + rilpivirine Cabenuva Antiretroviral agent 2020/03/19
Caplacizumab Cablivi Antithrombotic agent 2020/09/04
Baloxavir marboxil Xofluza Antiviral agent 2020/02/19
Indacaterol + glycopyrronium bromide + mometasone Enerzair Breezhaler Asthma medication 2020/11/05
Infliximab Avsola Biological response modifier 2020/06/01
Teriparatide Osnuvo Bone formation agent 2020/10/27
Voretigene Luxturna Cellular and gene therapy 2020/10/13
Onasemnogene Zolgensma Cellular and gene therapy 2021/02/04
Galcanezumab Emgality CGRP binding antibody 2019/10/02
Elexacaftor + tezacaftor + ivacaftor Trikafta Cystic fibrosis transmembrane conductance regulator correctors 2021/06/22
Etonogestrel Nexplanon Hormonal contraceptive 2020/08/17
Tibolone Tibella Hormone replacement therapy 2020/07/29
Glucagon Baqsimi Hyperglycemic agent 2019/11/20
Eszopiclone Lunesta Hypnotic 2020/10/20
Syndicate content